BMY-28271
BMY-28271 is an orally active cephalosporin. BMY-28271 has a widely expanded spectrum with high activity against gram-positive and gram-negative bacteria. BMY-28271 is a poor substrate for various beta-lactamases. BMY-28271 can be used for the research of infection[1].
Product Specifications
CAS Number
107888-50-6
UNSPSC
12352005
Target
Bacterial
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Infection
Smiles
CC(OC(C)OC(C1=C(/C=C\C)CS[C@@]([C@@H]2NC(/C(C3=CSC(N)=N3)=N\O)=O)([H])N1C2=O)=O)=O
Molecular Formula
C19H21N5O7S2
Molecular Weight
495.53
References & Citations
[1]Matsui H, et al. Antimicrobial activity and stability to beta-lactamase of BMY-28271, a new oral cephalosporin ester. Antimicrob Agents Chemother. 1990 Apr;34 (4) :555-61.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC880181-100 1x 100 µL
CD59 (heavy chain of Protectin) (BRA-10G), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040276-100 1x 100 µL
TAG-72 / CA72.4 (B72.3), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400003-100 1x 100 µL
CD45RO (UCHL-1), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400689-500 1x 500 µL
Cytokeratin 8 (K8.8), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC741571-100 1x 100 µL
GCDFP-15 (Gross Cystic Disease Fluid Protein 15) (Breast Marker) (PIP/1571), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details